Dissolved and financials
CVR: 31262488
DKK -93,000
Gross profit
Net result: DKK 88,447,000
No current owners
CVR · view owners
No current management
CVR · view management
Dissolved
Ceased 22 December 2025
CVR · view overview
0 employees
Annual report 2022 · average
Director role ended: NORDIC BIOTECH GENERAL PARTNER ApS
CVR · 22/12/2025
View the full event history
NORDIC BIOTECH OPPORTUNITY FUND K/S was a Danish company of the type Kommanditselskab based in Hellerup, founded in 2008. The company has been dissolved on 22 December 2025. The company was registered under the industry Anden finansiel formidling i.a.n.. According to the 2022 annual report, the company had an average of 0 employees. In 2024, the company reported a gross profit of DKK -93,000 and a net result of DKK 88,447,000 compared with DKK 1,331,000 the year before. Equity in the 2024 report amounted to DKK 111,542,000.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202401/01/2024 – 31/12/2024 | -93K | 88.4M | 111.6M | 111.5M | - | |
| 202301/01/2023 – 31/12/2023 | -107K | 1.3M | 23.2M | 23.1M | - | |
| 202201/01/2022 – 31/12/2022 | - | -38.9M | 21.8M | 21.8M | 0 | |
| 202101/01/2021 – 31/12/2021 | - | -5.2M | 60.7M | 60.6M | 0 | |
| 202001/01/2020 – 31/12/2020 | - | -1.1M | 65.9M | 65.9M | 0 | |
| 201901/01/2019 – 31/12/2019 | - | 11.4M | 67.1M | 67M | 0 | |
| 201801/01/2018 – 31/12/2018 | - | -187.7M | 55.6M | 55.6M | - | |
| 201701/01/2017 – 31/12/2017 | - | 653M | 243.4M | 243.2M | - | |
| 201601/01/2016 – 31/12/2016 | - | -214.5M | 1.1B | 1.1B | - | |
| 201501/01/2015 – 31/12/2015 | - | 16.1M | 1.3B | 1.3B | - | |
| 201401/01/2014 – 31/12/2014 | -153K | 595.3M | 1.3B | 1.3B | - | |
| 201301/01/2013 – 31/12/2013 | -133K | 238.7M | 725.1M | 725M | - | |
| 201201/01/2012 – 31/12/2012 | - | 416M | 475.9M | 475.8M | - |
Screen owners and management against the Danish FSA's official PEP lists
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationNo. NORDIC BIOTECH OPPORTUNITY FUND K/S is registered in the Danish CVR register with the status Dissolved and ceased on 22 December 2025.
The CVR number of NORDIC BIOTECH OPPORTUNITY FUND K/S is 31262488.
In 2024, NORDIC BIOTECH OPPORTUNITY FUND K/S reported a gross profit of DKK -93,000.
NORDIC BIOTECH OPPORTUNITY FUND K/S had an average of 0 employees in the 2022 financial year according to the annual report.
NORDIC BIOTECH OPPORTUNITY FUND K/S was founded on 7 February 2008.
NORDIC BIOTECH OPPORTUNITY FUND K/S was registered under the industry Anden finansiel formidling i.a.n. (industry code 649990).
As of December 22, 2025, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of NORDIC BIOTECH OPPORTUNITY FUND K/S.
As of December 22, 2025, NORDIC BIOTECH GENERAL PARTNER ApS has stepped down as director of NORDIC BIOTECH OPPORTUNITY FUND K/S.
NORDIC BIOTECH OPPORTUNITY FUND K/S was dissolved on December 22, 2025.
NORDIC BIOTECH OPPORTUNITY FUND K/S has published its annual report for 2024. Gross profit came to DKK -93,000, and the net result was DKK 88,447,000.
NORDIC BIOTECH OPPORTUNITY FUND K/S has published its annual report for 2023. Gross profit came to DKK -107,000, and the net result was DKK 1,331,000.
NORDIC BIOTECH OPPORTUNITY FUND K/S has published its annual report for 2022. The net result was DKK -38,875,000.
As of June 12, 2023, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of NORDIC BIOTECH OPPORTUNITY FUND K/S.
As of June 12, 2023, EY Godkendt Revisionspartnerselskab has stepped down as auditor of NORDIC BIOTECH OPPORTUNITY FUND K/S.
NORDIC BIOTECH OPPORTUNITY FUND K/S has published its annual report for 2021. The net result was DKK -5,233,000.
NORDIC BIOTECH OPPORTUNITY FUND K/S has published its annual report for 2020. The net result was DKK -1,138,000.
NORDIC BIOTECH OPPORTUNITY FUND K/S has published its annual report for 2019. The net result was DKK 11,432,000.
NORDIC BIOTECH OPPORTUNITY FUND K/S has published its annual report for 2018. The net result was DKK -187,652,000.
NORDIC BIOTECH OPPORTUNITY FUND K/S has published its annual report for 2017. The net result was DKK 653,031,000.
NORDIC BIOTECH OPPORTUNITY FUND K/S has published its annual report for 2016. The net result was DKK -214,538,000.
NORDIC BIOTECH OPPORTUNITY FUND K/S has published its annual report for 2015. The net result was DKK 16,131,000.
NORDIC BIOTECH OPPORTUNITY FUND K/S has published its annual report for 2014. Gross profit came to DKK -153,000, and the net result was DKK 595,282,000.
As of October 10, 2014, EY Godkendt Revisionspartnerselskab has been appointed auditor of NORDIC BIOTECH OPPORTUNITY FUND K/S.
As of October 10, 2014, JUT NR. 2180 A/S has stepped down as auditor of NORDIC BIOTECH OPPORTUNITY FUND K/S.
NORDIC BIOTECH OPPORTUNITY FUND K/S has published its annual report for 2013. Gross profit came to DKK -133,000, and the net result was DKK 238,656,000.
NORDIC BIOTECH OPPORTUNITY FUND K/S has published its annual report for 2012. The net result was DKK 415,972,033.
As of July 12, 2012, JUT NR. 2180 A/S has been appointed auditor of NORDIC BIOTECH OPPORTUNITY FUND K/S.
As of July 12, 2012, EY Danmark A/S has stepped down as auditor of NORDIC BIOTECH OPPORTUNITY FUND K/S.
As of February 7, 2008, NORDIC BIOTECH GENERAL PARTNER ApS is registered as director of NORDIC BIOTECH OPPORTUNITY FUND K/S.
NORDIC BIOTECH OPPORTUNITY FUND K/S was founded on February 7, 2008.
As of January 31, 2008, EY Danmark A/S has been appointed auditor of NORDIC BIOTECH OPPORTUNITY FUND K/S.

Uneven Bits ApS is an independent IT consultancy founded and operated by Klaus Byskov Pedersen. With deep expertise in software architecture and systems design, I help organizations build robust, scalable, and maintainable technical solutions. Whether you need strategic guidance on technology decisions, hands-on architecture work, or help navigating complex technical challenges, I bring focused expertise and a practical approach to every engagement.

Selskabets formål er IT- og kommunikationsvirksomhed samt virksomhed i øvrigt, der efter bestyrelsens skøn står i forbindelse hermed.

Selskabets formål er at udvikle, markedsføre, sælge og implementere software produkter til brug ved indkøbsstyring og dermed efter bestyrelsens skøn beslægtet virksomhed

Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.

Companies in the same industry and area
CVR 14352376
CVR 10037964
CVR 10517591
CVR 10964679
CVR 10977940